Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04103580 · ClinicalTrials.gov registry record · NA
Caregiver Speaks: A Technologically Mediated Storytelling Intervention
A NA study of Alzheimer Disease, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 457
- Enrollment target
- 1
- Study location
NCT04103580: Completed NA study of Alzheimer Disease, sponsored by Washington University School of Medicine.
NCT04103580 is a NA study of Alzheimer Disease that has completed, run by Washington University School of Medicine. The registered enrollment target is 457 participants, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04103580, a NA study of Alzheimer Disease, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 457 participants
- Enrollment target
- 1
- Study location
Study Summary
Caregiver speaks is a randomized trial of a Photo elicitation intervention for caregivers of Alzheimers patients.
Primary Outcome
Caregiver anxiety measure. Response options range from 0 (not at all) to 3 (nearly every day), with total scores ranging from 0 to 21. Higher scores indicate more anxiety.
Conditions Studied
Interventions
- BEHAVIORAL Photo elicitation
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 457 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
What the finished NCT04103580 record still lists
NCT04103580 is an interventional study that assigns participants to a tested intervention. The registered 457 participants enrollment target is mid-sized for trials with a published cap, below the 2,749-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Photo elicitation is the first listed.
NCT04103580 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04103580 about?
NCT04103580 is a clinical study titled "Caregiver Speaks: A Technologically Mediated Storytelling Intervention". Caregiver speaks is a randomized trial of a Photo elicitation intervention for caregivers of Alzheimers patients.
What is the current status of trial NCT04103580?
This trial is currently completed. It is a NA study. The enrollment target is 457 participants. The study started on 2020-03-01. Estimated completion is 2023-08-31.
What conditions does trial NCT04103580 study?
This clinical trial studies the following conditions: Alzheimer Disease.
What interventions are being tested in trial NCT04103580?
The interventions under investigation include: Photo elicitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04103580?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04103580 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04103580's enrollment target sits among peer trials
457 55th of 306 higher than 252 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05856942 · 458 participants · NA
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
- NCT06201676 · 458 participants · Phase 4
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
- NCT04462302 · 456 participants · NA
An Internet-based Program to Help Cancer Survivors Manage Pain
- NCT06254612 · 456 participants · Phase 2
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI